Treatment with insulin detemir provides improved glycaemic control and less weight gain compared to NPH insulin in people with diabetes

被引：0

作者：

Garber, AJ

Kim, H

Draeger, E

机构：

[1] Baylor Coll Med, Dept Med, Endocrinol Sect, Houston, TX 77030 USA

[2] Novo Nordisk AS, Clin Stat, Gladsaxe, Denmark

[3] Novo Nordisk AS, Reg Europe, Med Affairs NNRE, CDC Europe, Zurich, Switzerland

来源：

DIABETOLOGIA | 2004年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

150

引用

页码：A58 / A58

页数：1

共 50 条

[1] Treatment with insulin detemir provides improved glycemic control and less weight gain compared to NPH insulin in people with diabetes
Garber, AJ
Olsen, KJ
Draeger, E
[J]. DIABETES, 2004, 53 : A125 - A125
[2] Insulin detemir offers improved glycaemic control, less weight gain, and flexible timing of administration compared to NPH insulin.
Home, PD
Bartley, P
Landin-Olsson, M
Russell-Jones, D
Hylleberg, B
Draeger, E
[J]. DIABETOLOGIA, 2003, 46 : A7 - A7
[3] Insulin detemir provides superior glycaemic control compared with NPH insulin
Larsen, J. J.
Heller, S.
Pedersen, C. B.
[J]. DIABETOLOGIA, 2007, 50 : S393 - S394
[4] Insulin detemir offers improved glycemic control, less weight gain, and flexible timing of administration compared to NPH insulin
Home, P
Bartley, P
Landin-Olsson, M
Russell-Jones, D
Hylleberg, B
Draeger, E
[J]. DIABETES, 2003, 52 : A122 - A122
[5] Superior glycaemic control with insulin detemir compared with NPH
Heller, Simon
Pedersen, Claus B.
Larsen, Jens
[J]. DIABETES, 2007, 56 : A537 - A537
[6] Treatment with insulin detemir in combination with oral agents is associated with less risk of hypoglycaemia and less weight gain than NPH insulin at comparable levels of glycaemic improvement in people with Type 2 diabetes
Hermansen, K
Derezinski, T
Kim, H
Gall, MA
[J]. DIABETOLOGIA, 2004, 47 : A273 - A274
[7] Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia
Davies, Melanie J.
Derezinski, Tadeusz
Pedersen, Claus Bang
Clauson, Per
[J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2008, 10 (04) : 273 - 277
[8] Insulin detemir improves glycemic control and reduces the risk of weight gain in comparison to NPH insulin in diabetes
Draeger, E
Kim, H
[J]. OBESITY RESEARCH, 2004, 12 : A43 - A43
[9] Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes - A randomized clinical trial
Home, P
Bartley, P
Russell-Jones, D
Hanaire-Broutin, H
Heeg, JE
Abrams, P
Landin-Olsson, M
Hylleberg, B
Lang, H
Draeger, E
[J]. DIABETES CARE, 2004, 27 (05) : 1081 - 1087
[10] Lower rate of hypoglycaemia but comparable glycaemic control with insulin detemir compared to NPH insulin in patients with type 1 diabetes
Hermansen, K.
Heller, S.
Andersen, M.
Russell-Jones, D. L.
[J]. DIABETOLOGIA, 2009, 52 : S359 - S359

← 1 2 3 4 5 →